Haemonetics (HAE) Non Operating Income (2009 - 2026)

Haemonetics' Non Operating Income history runs 18 years deep, the most recent figure standing at -$5.4 million for Q1 2026.

• In Q1 2026, Non Operating Income fell 798.66% year-over-year to -$5.4 million; the TTM figure through Mar 2026 stood at -$28.7 million (down 194.52% YoY), while the FY2026 annual figure was -$28.7 million, down 194.52% from the prior year.
• Non Operating Income was -$5.4 million for Q1 2026 at Haemonetics, up from -$7.4 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $7.0 million in Q2 2024 to a low of -$9.1 million in Q4 2024.
• Historically, Non Operating Income has averaged -$4.1 million across 5 years, with a median of -$4.8 million in 2022.
• The sharpest annual moves came in 2024 and 2026: Non Operating Income jumped 436.25% in 2024, then plunged 798.66% in 2026.
• A 5-year view of Non Operating Income shows it stood at -$1.1 million in 2022, then sank by 84.74% to -$1.9 million in 2023, then plunged by 367.52% to -$9.1 million in 2024, then advanced by 18.56% to -$7.4 million in 2025, then climbed by 27.58% to -$5.4 million in 2026.
• The last three Non Operating Income figures came in at -$5.4 million (Q1 2026), -$7.4 million (Q4 2025), and -$7.2 million (Q3 2025), per Business Quant data.